Aldesleukin Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.1 Immunomodulators Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Manufacturers of Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage 's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 18 to 18 Million Units18 (18)24 hourlySc18 million units given Subcutaneus once daily for 5 day, followed by 2 days rest for the first week. for the next 3 week 18 million uints on day 1 & 2 of each week and 9 million units on day 3 to 5 of each week followed by 2 week rest. This 4 week cycle may be repeated after an interval of 1 week. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Back to top Manufacturers of Aldesleukin in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Aldesleukin Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.1 Immunomodulators Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Manufacturers of Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage 's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 18 to 18 Million Units18 (18)24 hourlySc18 million units given Subcutaneus once daily for 5 day, followed by 2 days rest for the first week. for the next 3 week 18 million uints on day 1 & 2 of each week and 9 million units on day 3 to 5 of each week followed by 2 week rest. This 4 week cycle may be repeated after an interval of 1 week. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Back to top Manufacturers of Aldesleukin in Pakistan Back to top Previous Drug Generic - Next Drug Generic